Page 20 - Pharmaceutical Sciences News Today

A study led by University of California, Irvine researchers has revealed a connection between blood levels of omega-3 and the inflammatory biomarker interleukin

<p>Researchers have identified a receptor protein known as CHRM1 as a key player in prostate cancer cells’ resistance to docetaxel, a commonly used chemotherapy drug to treat advanced cancer that has spread beyond the prostate. The study showed that using the drug dicyclomine to block CHRM1 in resistant prostate cancer cell lines and an animal model based on patient-derived resistant tissue restored docetaxel’s ability to kill cells and stop tumor growth. Dicyclomine is...

Nevada now boasts more than 9,400 jobs across 1,000 biotech companies statewide.

New WSU research could ultimately help extend the lives of those with prostate cancer, one of the leading causes of cancer deaths among men.

Researchers have identified a receptor protein known as CHRM1 as a key player in prostate cancer cells' resistance to docetaxel, a commonly used chemotherapy drug to treat advanced cancer that has spread beyond the prostate.

In prostate cancer, the minimum effective dose of docetaxel may be reduced when combined with dicyclomine, in contrast to its solo administration.

Returning from India after visiting my elderly parents each winter, is always filled with mixed emotions; a confluence of feelings, that of regret for not

HUNTINGTON — Marshall University professors Daniel Brazeau, Ph.D., and Gayle Brazeau, Ph.D., participated in an American Association of Colleges of Pharmacy delegation to Havana, Cuba, this month as part of

Read about an Indian-origin pharmaceutical scientist from Suryapet who has been elected as a Fellow of Royal Society of Chemistry (FRSC) in the United Kingdom. Discover the achievements and contributions of Dr Shashi Ravi Suman Rudrangi.

Hospital pharmacists can play an important role in advocating for, designing, and implementing various policies to optimize care.